Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Fish and Richardson
Express Scripts
US Army
Boehringer Ingelheim
Argus Health
Queensland Health

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040547

« Back to Dashboard

NDA 040547 describes METHIMAZOLE, which is a drug marketed by Casi Pharms Inc, Eci Pharms Llc, Heritage Pharma, Mylan, Rising Pharms Inc, and Sun Pharm Inds Inc, and is included in seven NDAs. It is available from thirteen suppliers. Additional details are available on the METHIMAZOLE profile page.

The generic ingredient in METHIMAZOLE is methimazole. There are three drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the methimazole profile page.
Summary for 040547
Applicant:Eci Pharms Llc
Therapeutic Class:Hormonal Agents, Suppressant (Thyroid)
Formulation / Manufacturing:see details
Pharmacology for NDA: 040547
Medical Subject Heading (MeSH) Categories for 040547
Suppliers and Packaging for NDA: 040547
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHIMAZOLE methimazole TABLET;ORAL 040547 ANDA Exact-Rx, Inc. 42808-405 N 42808-405-01
METHIMAZOLE methimazole TABLET;ORAL 040547 ANDA ECI Pharmaceuticals, LLC 51293-820 N 51293-820-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Feb 18, 2005TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Feb 18, 2005TE:ABRLD:No

Profile for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength20MG
Approval Date:Feb 18, 2005TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Harvard Business School
Daiichi Sankyo
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.